Please provide your email address to receive an email when new articles are posted on . ANAHEIM, Calif. — Among patients with stable atherosclerotic vascular disease, a regimen of rivaroxaban 2.5 mg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results